Literature DB >> 22152746

Irreversible visual loss secondary to excessive topical steroid use in eczema.

Charles Lim Fat1, Thorfinn Leslie.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22152746      PMCID: PMC3162174          DOI: 10.3399/bjgp11X594054

Source DB:  PubMed          Journal:  Br J Gen Pract        ISSN: 0960-1643            Impact factor:   5.386


× No keyword cloud information.
  6 in total

1.  Visual loss caused by corticosteroid-induced glaucoma: how to avoid it.

Authors:  George L Spaeth; Daniela S Monteiro de Barros; Scott J Fudemberg
Journal:  Retina       Date:  2009-09       Impact factor: 4.256

Review 2.  Effects of glucocorticoids on the trabecular meshwork: towards a better understanding of glaucoma.

Authors:  R J Wordinger; A F Clark
Journal:  Prog Retin Eye Res       Date:  1999-09       Impact factor: 21.198

Review 3.  Ocular effects of topical and systemic steroids.

Authors:  L Renfro; J S Snow
Journal:  Dermatol Clin       Date:  1992-07       Impact factor: 3.478

Review 4.  Corticosteroid-induced glaucoma: a review of the literature.

Authors:  J P Kersey; D C Broadway
Journal:  Eye (Lond)       Date:  2006-04       Impact factor: 3.775

5.  Altered peripheral sensitivity to glucocorticoids in primary open-angle glaucoma.

Authors:  John Stokes; Brian R Walker; Jill C Campbell; Jonathan R Seckl; Colm O'Brien; Ruth Andrew
Journal:  Invest Ophthalmol Vis Sci       Date:  2003-12       Impact factor: 4.799

6.  Facial eczema and sight-threatening glaucoma.

Authors:  Jonathan J Ross; Aby Jacob; Mark Batterbury
Journal:  J R Soc Med       Date:  2004-10       Impact factor: 18.000

  6 in total
  2 in total

Review 1.  Ocular complications associated with systemic medications used in allergy/immunology practice.

Authors:  Avinash Gurbaxani; Clare L Fraser; Simon E Skalicky; Peter McCluskey
Journal:  Curr Allergy Asthma Rep       Date:  2013-06       Impact factor: 4.806

2.  The trilateral link between anaesthesia, perioperative visual loss and Flammer syndrome.

Authors:  Rossiana I Bojinova; Katarzyna Konieczka; Peter Meyer; Margarita G Todorova
Journal:  BMC Anesthesiol       Date:  2016-02-04       Impact factor: 2.217

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.